Last reviewed · How we verify

Ropivacaine concentration high — Competitive Intelligence Brief

Ropivacaine concentration high (Ropivacaine concentration high) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Local anesthetic (amide). Area: Anesthesia.

marketed Local anesthetic (amide) Voltage-gated sodium channels Anesthesia Small molecule Live · refreshed every 30 min

Target snapshot

Ropivacaine concentration high (Ropivacaine concentration high) — Oslo University Hospital. Ropivacaine is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and conduction of nerve impulses.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Ropivacaine concentration high TARGET Ropivacaine concentration high Oslo University Hospital marketed Local anesthetic (amide) Voltage-gated sodium channels
Continuous Infusion of ropivacaine 0.2% Continuous Infusion of ropivacaine 0.2% University of California, San Diego marketed Local anesthetic Voltage-gated sodium channels
Topical Benzocaine 20% Topical Benzocaine 20% Nourhan M.Aly marketed Local anesthetic Voltage-gated sodium channels
Topical Benzocaine Topical Benzocaine University of Maryland, Baltimore marketed Local anesthetic Voltage-gated sodium channels
Topical Lidocaine 4% Cream Topical Lidocaine 4% Cream Children's Hospital of Philadelphia marketed Local anesthetic Voltage-gated sodium channels
Topical liquid lidocaine Topical liquid lidocaine OHSU Knight Cancer Institute marketed Local anesthetic Voltage-gated sodium channels
MEPIVACAÍNE MEPIVACAÍNE Complexo Hospitalario Universitario de A Coruña marketed Local anesthetic (amide) Voltage-gated sodium channels

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Local anesthetic (amide) class)

  1. Poznan University of Medical Sciences · 4 drugs in this class
  2. Nantes University Hospital · 3 drugs in this class
  3. Bozyaka Training and Research Hospital · 2 drugs in this class
  4. ASST Gaetano Pini-CTO · 2 drugs in this class
  5. Centre Hospitalier Universitaire de Nīmes · 1 drug in this class
  6. Chiang Mai University · 1 drug in this class
  7. Beijing Tiantan Hospital · 1 drug in this class
  8. Complejo Hospitalario Universitario de Granada · 1 drug in this class
  9. Ciusss de L'Est de l'Île de Montréal · 1 drug in this class
  10. China Medical University, China · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Ropivacaine concentration high — Competitive Intelligence Brief. https://druglandscape.com/ci/ropivacaine-concentration-high. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: